Overview
"Albert W. Wu is Professor of Health Policy and Management and Medicine, with joint appointments in Epidemiology, International Health, Medicine and Surgery. He received BA and MD degrees from Cornell University, and completed an Internal Medicine residency at the Mount Sinai Hospital and UC San Diego. He was a Robert Wood Johnson Clinical Scholar at UCSF and received an MPH from UC Berkeley. His research and teaching focus on patient outcomes and quality of care. He was the first to measure the quality of life impact of antiretroviral therapy in HIV clinical trials. He developed the MOS-HIV health survey, and other questionnaires to measure quality of life, adherence, satisfaction, attitudes and behaviors for people with chronic disease. He was co-founder and director of the outcomes research committee of the AIDS Clinical Trials Group of the NIH, and President of the International Society for Quality of Life. He advises many US and international organizations on PRO methods. He is director of the Johns Hopkins Center for Health Services and Outcomes Research, He has studied the handling of medical errors since 1988, was a member of the Institute of Medicine committee on identifying and preventing medication errors, and was Senior Adviser for Patient Safety to WHO in Geneva. His current research is on incorporating PROs into the electronic health record, PRO-performance measures for primary care, supporting healthcare workers after adverse events, and creating a network community based organizations. He has authored over 400 peer review publications. and is co-author of the recent book ""New Horizons in Patient Safety, Understanding Communication. He leads the PhD program in health services research, the Masters of Applied Science in Patient Safety & Healthcare Quality, and the Certificate program in Quality, Patient Safety and Outcomes Research in the Johns Hopkins Bloomberg School of Public Health. He maintains a clinical practice in general internal medicine.".
Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS).
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Floor 7, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Bayview Medical Center
Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as an Advanced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.
Kathleen Neuzil is an Infectious Disease provider in Baltimore, Maryland. Dr. Neuzil is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). Her top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.